$17.18 B
Share price
Change (1 day)
Change (1 year)
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) Fails to deliver data

Key failure to deliver metrics for Abiomed:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Abiomed (ABMD) - 3 month history

Number of shares, 3 month chart

Biweekly Failures to deliver volume for Abiomed (ABMD) - since 2013

Volume in USD (price x number of shares), data since 2013

Abiomed (ABMD) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2022$33.77 M-38.73%
2021$55.12 M177.91%
2020$19.83 M-81.11%
2019$0.10 B9.91%
2018$95.55 M270.12%
2017$25.81 M-23.06%
2016$33.55 M58.42%
2015$21.17 M-26.41%
2014$28.78 M1249.72%
2013$2.13 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$24.1 M$53.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
$5.85 M$25.73 M๐Ÿ‡บ๐Ÿ‡ธ USA
$0.13 M$2.85 M๐Ÿ‡บ๐Ÿ‡ธ USA